Morepen Laboratories Ltd

NSE: MOREPENLAB · BSE: 500288 · Pharmaceuticals & Biotechnology · 33 announcements

Share price: ₹146.97
Market cap: ₹8,053 Cr
Revenue (annual): ₹1,806 Cr
Net profit (annual): ₹94.88 Cr
P/E (TTM): 57.3×Sector 47.3×
Promoter holding: 35.65%+0.00% QoQ
FII holding: 1.46%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

6 May 2026 18:16 IST BSE

Morepen Laboratories Fund Raise of ₹200 Cr

Morepen Laboratories Ltd submitted its Monitoring Agency Report for the quarter ended March 31, 2026. The report details the utilization of ₹200 Crore raised via QIP, including ₹109.23 Crore deployed for modernization and ₹66.29 Crore for working capital. The company extended the utilization timeline for medical device development at Baddi to March 2027.

Value: ₹200.0 Cr

Read the filing ↗